Innovative Technology SaiOx has developed Hespiro™, a novel respiratory assist device utilizing heliox technology, which addresses respiratory diseases like COPD and COVID-19, indicating a strong potential for partnerships with hospitals and healthcare providers seeking advanced respiratory solutions.

Recognized Market Presence With recent accolades such as Venture Madness 2021 winner and finalist positions in regional innovation awards, SaiOx demonstrates strong credibility and growth momentum, making it an attractive candidate for investors and supply chain partners aiming to support innovative medical devices.

Strategic Partnerships The company's collaboration with XrossFusion in India highlights a strategic opportunity to expand into emerging markets, providing oxygen-saving respiratory equipment to hospitals, which could be leveraged to explore further international distribution channels.

Funding & Revenue Range Although SaiOx currently operates with modest revenues ($0-1M) and funding ($205K), its developmental stage presents an opportunity for investment or sales partnerships aimed at scaling manufacturing, marketing, and distribution efforts for its innovative respiratory device.

Industry Positioning Positioned among key players in medical equipment manufacturing with recognition and awards, SaiOx offers an opportunity for strategic partnerships focused on enhancing respiratory care solutions within hospitals, clinics, and health systems looking to adopt cutting-edge medical technologies.